XORTX THERAPEUTICS INC (XRTX)

CA98420Q3061 - Common Stock

1.2  +0.03 (+2.57%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
4.44M6.05M10.29M2.62M1.04M
Research and Development
310.19K2.42M6.76M611.42K207.20K
Selling, General, and Administrative Expenses
4.02M3.49M3.47M1.99M820.03K
Operating Income
-4.44M-6.05M-10.29M-2.62M-1.04M
Interest Income/Expense
3.93M3.89M3.50M2.60M-7.25K
Other Income/Expense
-224.49K0.00-926.46K-1.16M-635.00
Non Recurring Items
N/AN/A0.000.0091.06K
Income Before Taxes
-736.66K-2.16M-7.72M-1.18M-959.30K
Net Income
-736.66K-2.16M-7.72M-1.18M-959.30K
EBITDA
-4.33M-5.91M-10.23M-2.60M-1.03M
 
Per Share Data
EPS Diluted Total Ops
-0.04-1.09-5.22-1.08-1.30
 
Statistics

All data in USD

Charts